BST2 and infection: While the molecular topology of the BST-2 molecules that restrict virion release thus remains to be resolved, the augmentation of BST-2 activity and the inhibition of viral antagonists such as Vpu likely represent new approaches to the prevention and treatment of infections due to enveloped viruses.